Market Overview:
The global pathological microscopes market size is estimated to accrue USD 523.20 million by 2023, states Market Research Future (MRFR) in its latest report. Increasing prevalence of various diseases is the primary driver of the market. High incidence of cancer, tuberculosis, and diabetes among adults and children has called for advanced diagnostic procedures which can detect the symptoms at an early stage. This is expected to bolster the demand of the pathological microscopes market among its end-users. The market can exhibit 4.50% CAGR over the forecast period (2018-2023).
Drug discovery and development is an emerging area which requires microscopes for expediting the commercialization of products. Customized solutions offered by Pathological Microscopes Market manufacturers to minimize the iteration of assays and streamline the workflow is likely to work in the market’s favor. Funding by pharmaceutical companies can offer new opportunities to players. This is evident by the spending budget of USD 149.8 billion by the International Federation of Pharmaceutical Manufacturers & Associations in 2015.
Automation of laboratories which includes devices that gel with advanced technologies such as augmented reality which expands the image size and resolution is likely to boost market demand. In addition, emergence of various public and private diagnostic centers for testing of diseases is touted to augur well for the pathological microscopes market. These centers serve as a focal point for testing of various diseases and reducing the burden of patients on hospitals.
High purchase and maintenance costs of microscopes can pose a challenge to the market. In addition, unfavorable reimbursement schemes which cover only government-run diagnostic centers can restrain market growth.
Segmentation:
The pathological microscopes market is segmented by type, application, and end-user.
By type, electron microscope held close to 41.4% share in 2017, followed by optical microscope (18.8%), compound microscope (13.5%), digital microscope (5.4%), fluorescence microscope (4.4%), and others (16.5%). Electron microscopes can generate nearly USD 217.81 million by 2023 owing to their application in life sciences. Prevalence of diseases such as anemia and leukemia which require the need of electron microscopes lend credence to the segment valuation. But digital microscopes can exhibit the highest CAGR of 5.01% during the forecast period to accumulate USD 28.90 million for the pathological microscopes market by 2023.
By application, bodily fluids accounted for 79.4% share of the pathological microscopes market in 2017, followed by tissue scanning (12.7%), and others (7.9%). Bodily fluids can generate USD 418.84 million for the pathological microscopes market by 2023. This can be attributed to use of fluid samples to identify the presence of diseases such as tuberculosis in the human body. High prevalence of blood disorders is driving the segment growth. On the other hand, tissue scanning is touted to accumulate USD 67.94 million by 2023. High prevalence of cancer and use of digital microscopes to detect abnormal tissue growth can fuel the segment growth.
By end-user, pathology & diagnostic laboratories accounted for 45.2% market share in 2017, followed by hospitals & clinics (38.6%), forensic laboratories (11.5%), and others (4.7%). Hospitals & clinics will be the biggest end-user of the pathological microscopes market by 2023. It can generate USD 206.25 million by the end of the forecast period owing to the setup of various branches of hospital chains to handle high patient volume. On the other hand, pathology & diagnostic laboratories can generate USD 239.73 million by 2023 thanks to possessing various skilled personnel and use of hematology, clinical microbiology, and molecular pathology for rapid diagnosis of diseases.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7319
Regional Analysis:
Region-wise segmentation of the pathological microscopes market includes Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas accounted for 37.5% market share in 2017, followed by APAC (35%), Europe (20.1%), and MEA (7.4%).
The Americas pathological microscopes market can reach a size of USD 190.98 million by 2023 owing to the uptick noticed in the setup of research and academic institutes. High incidence of chronic diseases coupled with investments in research and development (R&D) are factors expected to bolster market demand till 2023.
The APAC region is expected to generate USD 192.58 million by 2023, at a CAGR of 5.36% during the forecast period. Abundance of researchers coupled with investments in research and development are likely to bolster market demand by 2023. Presence of players such as Olympus and Nikon in Japan are expected to expedite the development of microscopes.
On the other hand, the Europe pathological microscopes market owing to rapid expansion of the life sciences sector. In addition, funding by governments and rise of public-private partnerships to accelerate development of drugs is expected to push its size to USD 103.99 million by 2023.
Competitive Analysis:
Eminent names in the pathological microscopes market are Leica Biosystems Nussloch GmbH (Germany), Sakura Finetek USA, Inc. (U.S.), ZEISS International (Germany), Celestron LLC (U.S.), Euromex Microscopen BV (The Netherlands), Olympus Corporation (Japan), Bruker Corporation (U.S.), Labomed, Inc. (U.S.), Nikon Corporation (Japan), and Hitachi High-Technologies Corporation (Japan).
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/pathological-microscopes-market-7319
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
This report on the Global Pathological Microscopes Market provides a global 360-degree perspective of the industry while taking into consideration historical data as well as providing accurate estimations of the future scope of the market.
This make it easier for the stakeholders of the report to utilize this information and incorporate changes in their business policies and be well informed about the market dynamics.
It also provides an insight into the competitive landscape of the market highlighting key competitors, major manufacturers dominating the Pathological Microscopes Market, while also providing an analysis of the market share and revenue generation figures.Ask for report free sample with complete TOC and list of tables/figures @ https://www.datalibraryresearch.com/sample-request/pathological-microscopes-market-2180Global Pathological Microscopes Market Competitive Analysis:· Nikon Corporation· Leica Biosystems Nussloch GmbH· Olympus Corporation· ZEISS International· Sakura Finetek USA, Inc.· Celestron, LLC.· Labomed Inc.· Hitachi High-Technologies Corporation· Bruker Corporation· Euromex Microscopen BV Drivers & ConstraintsThe report largely stresses on the importance of market dynamics in understanding the Pathological Microscopes Market industry.
Additionally, the report also calls out regions that have showed maximum growth in the past as well as regions that emerged as leaders of the market in historic years.
Moreover, the report also lists out regions that are expected to show maximum potential for market growth in the years to come.
*All our reports are customizable as per customer requirementsThis study forecasts revenue and volume growth at global, regional, and country levels from 2016 to 2027.
The global Pathological Microscopes market report examines the market position and viewpoint of the market worldwide, from various angles, such as from the key player’s point, geological regions, types of product and application.
This Pathological Microscopes report highlights the key driving factors, constraint, opportunities, challenges in the competitive market.
It also offers thorough Pathological Microscopes analysis on the market stake, classification, and revenue projection.
It also includes company information of each market player, capacity, profit, Pathological Microscopes product information, price, and so on.The latest Pathological Microscopes market report published by Data Library Research offers a competency-based analysis and global market estimate, developed using evaluable methods, to provide a clear view of current and expected growth patterns.
The report also contains market analysis by geographic location across the globe as well as major markets.The key manufacturers covered in this report are @:- Nikon Corporation,Leica Biosystems Nussloch GmbH,Olympus Corporation,ZEISS International,Sakura Finetek USA, Inc.,Celestron, LLC.,Labomed Inc.,Hitachi High-Technologies Corporation,Bruker Corporation,Euromex Microscopen BV Download Latest PDF Sample Copy of this Report @ https://www.datalibraryresearch.com/sample-request/pathological-microscopes-market-2180?utm_source=free_medium=60The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.Research MethodologyThe data that has been collected is from a multitude of different services that include both primary and secondary sources.
The data also includes a list of the different factors that affect the Pathological Microscopes market either positively or negatively.
Speedy technological advances as well as automation integration drive the global digital pathology market.
Based on end-users, the global digital pathology market has been segmented into hospital & clinic, diagnostic centers, and research centers & academic institutes.
The research centers and academic institutes segment is expanding at the fastest growth rate in the global digital pathology market and is anticipated to reach the valuation of USD 3,778.4 Mn by the end of the assessment period.Regional AnalysisThe key markets of the global digital pathology market include North America, Europe, Asia Pacific and the Middle East & Africa.
Europe is the second largest market for digital pathology due to the presence of a robust healthcare sector and increased expenditure on healthcare facilities.
The Middle East & Africa market is projected to exhibit steady growth over the forecast period.Industry NewsPaige raised $100 million for additional support in order to accelerate the production of biomarkers as a therapeutic product, following two approvals last month for their artificial intelligence platforms for cancer pathology.
Owing to the lucrative growth opportunities offered by the market, there has been an influx of new players which further intensifies the competition.
